Livzon Pharmaceutical Group Inc Total Liabilities

Latest as of March 2026: CN¥8.61 Billion CNY ≈ $1.26 Billion USD

Livzon Pharmaceutical Group Inc total liabilities. Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has total liabilities worth CN¥8.61 Billion CNY (≈ $1.26 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Livzon Pharmaceutical Group Inc (000513) liquidity interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Livzon Pharmaceutical Group Inc (1992–2025)

Total liabilities of Livzon Pharmaceutical Group Inc from 1992 to 2025. This chart illustrates how Livzon Pharmaceutical Group Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Livzon Pharmaceutical Group Inc to evaluate the company's liquid asset resilience ratio.

Livzon Pharmaceutical Group Inc Competitors by Total Liabilities

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Beite Technology Co SHG:603009	China	CN¥1.87 Billion
Greif Inc NYSE:GEF-B	USA	$2.52 Billion
Benchmark Electronics Inc NYSE:BHE	USA	$1.10 Billion
TAG Immobilien AG F:TEG	Germany	€5.63 Billion
DB HiTek Co Ltd KO:000990	Korea	₩682.95 Billion
Select Energy Services Inc NYSE:WTTR	USA	$587.24 Million
By health SHE:300146	China	CN¥2.60 Billion
Shufersal TA:SAE	Israel	ILA10.24 Billion

Liability Composition Analysis (1992–2025)

This chart breaks down Livzon Pharmaceutical Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 000513 asset base.

Liquidity & Leverage Metrics

Livzon Pharmaceutical Group Inc Total Liabilities Ratios Explained

Livzon Pharmaceutical Group Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.59	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.36	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Livzon Pharmaceutical Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Livzon Pharmaceutical Group Inc (1992–2025)

The table below shows the annual total liabilities of Livzon Pharmaceutical Group Inc from 1992 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥8.20 Billion ≈ $1.20 Billion	-14.17%
2024-12-31	CN¥9.55 Billion ≈ $1.40 Billion	-7.08%
2023-12-31	CN¥10.28 Billion ≈ $1.50 Billion	+3.49%
2022-12-31	CN¥9.93 Billion ≈ $1.45 Billion	+23.21%
2021-12-31	CN¥8.06 Billion ≈ $1.18 Billion	+15.97%
2020-12-31	CN¥6.95 Billion ≈ $1.02 Billion	+21.92%
2019-12-31	CN¥5.70 Billion ≈ $834.27 Million	+0.24%
2018-12-31	CN¥5.69 Billion ≈ $832.26 Million	+21.94%
2017-12-31	CN¥4.66 Billion ≈ $682.51 Million	+36.23%
2016-12-31	CN¥3.42 Billion ≈ $500.98 Million	+4.77%
2015-12-31	CN¥3.27 Billion ≈ $478.16 Million	+1.47%
2014-12-31	CN¥3.22 Billion ≈ $471.21 Million	+8.74%
2013-12-31	CN¥2.96 Billion ≈ $433.36 Million	+20.70%
2012-12-31	CN¥2.45 Billion ≈ $359.04 Million	+54.19%
2011-12-31	CN¥1.59 Billion ≈ $232.86 Million	+55.58%
2010-12-31	CN¥1.02 Billion ≈ $149.67 Million	+13.79%
2009-12-31	CN¥898.92 Million ≈ $131.54 Million	-17.48%
2008-12-31	CN¥1.09 Billion ≈ $159.40 Million	+14.09%
2007-12-31	CN¥954.80 Million ≈ $139.72 Million	-11.31%
2006-12-31	CN¥1.08 Billion ≈ $157.53 Million	+16.36%
2005-12-31	CN¥925.20 Million ≈ $135.39 Million	-10.17%
2004-12-31	CN¥1.03 Billion ≈ $150.72 Million	+7.88%
2003-12-31	CN¥954.70 Million ≈ $139.70 Million	+31.31%
2002-12-31	CN¥727.05 Million ≈ $106.39 Million	+13.71%
2001-12-31	CN¥639.37 Million ≈ $93.56 Million	+10.00%
2000-12-31	CN¥581.24 Million ≈ $85.05 Million	-0.46%
1999-12-31	CN¥583.95 Million ≈ $85.45 Million	+24.88%
1998-12-31	CN¥467.61 Million ≈ $68.43 Million	-1.45%
1997-12-31	CN¥474.51 Million ≈ $69.44 Million	-13.27%
1996-12-31	CN¥547.10 Million ≈ $80.06 Million	+22.26%
1995-12-31	CN¥447.49 Million ≈ $65.48 Million	+81.43%
1994-12-31	CN¥246.65 Million ≈ $36.09 Million	-1.58%
1993-12-31	CN¥250.60 Million ≈ $36.67 Million	-21.37%
1992-12-31	CN¥318.71 Million ≈ $46.64 Million	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.45 Billion

CN¥16.77 Billion CNY

Market Cap Rank

#5286 Global

#861 in China

Share Price

CN¥28.52

Change (1 day)

+3.18%

52-Week Range

CN¥25.97 - CN¥37.60

All Time High

CN¥1418.81